Morocco is charging full speed toward turning cannabis into a life-changing medicine with the country exporting its first-ever shipment of medical hashish in partnership with Swiss company Medropharm in Morocco.
The first shipment landed at Geneva Airport on February 19, and will soon be available to customers.
According to Medropharm’s founder Patrick Widmer, this is a major breakthrough. “Medical hashish opens up new possibilities for treatment and expands the range of pharmaceutical cannabis products,” he said in a press statement.
For decades, Morocco has been one of the world’s largest hashish exporters, despite strict bans on production since 1974. But times have changed. In 2021, the government gave the go-ahead to cannabis farming for medical use only, sensing a golden opportunity too profitable to miss.
Experts in Morocco are working around the clock to develop the country’s pharmaceutical industry with cannabis-based drugs, aimed to alleviate serious health issues like chronic pain, epilepsy, and possibly cancer.
The National Agency for the Regulation of Cannabis-Related Activities is making sure everything runs smoothly. High-level meetings, factory inspections, and strict checks are all part of the plan for a fully controlled and legal cannabis industry that brings in millions of dollars and much-needed medical relief to patients.
Key production sites – Casablanca, Meknes, Marrakech, Taounate, and Bab Berred – have all been inspected to ensure they meet strict regulations. Farmers and cooperatives are also getting trained to grow high-quality cannabis.
The Ministry of Industry is throwing its full support behind the project, which could turn Morocco into a powerhouse in producing legal cannabis-based medicine.
